Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Dosage regimens should generally be individualised, depending on features of the patient that can alter the drug's pharmacokinetics (disposition in the body) or pharmacodynamics (therapeutic and adverse effects). It is usually good practice to start with a low dose, gradually increasing it acco...

Fuld beskrivelse

Bibliografiske detaljer
Hovedforfatter:	Aronson, J
Format:	Journal article
Sprog:	English
Udgivet:	2005

Lignende værker

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
af: Aronson, J, et al.
Udgivet: (2003)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
af: Aronson, J
Udgivet: (2016)

Balancing benefits and harms in health care.
af: Cuervo, L, et al.
Udgivet: (2003)

Lorcaserin in obesity: minimal benefits and ill-defined harms
af: Onakpoya, I, et al.
Udgivet: (2019)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
af: E. N. Bochanova
Udgivet: (2015-09-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
af: E. N. Bochanova
Udgivet: (2015-09-01)

Patentability of Pharmaceutical Dosage Regimens in Europe
af: Mahdi Zahedi, et al.
Udgivet: (2013-03-01)

Application of Monte Carlo simulation to optimise the dosage regimen of meropenem in patients with augmented renal clearance for Pseudomonas aeruginosa infection
af: Jia Hou, et al.
Udgivet: (2024-06-01)

Increasing Risks to the Health of the Invertebrates—Balancing between Harm and Benefit
af: Tatiana V. Kuznetsova, et al.
Udgivet: (2024-05-01)

ChatGPT and mental healthcare: balancing benefits with risks of harms
af: John Torous, et al.
Udgivet: (2023-10-01)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
af: Bruce Leff, et al.
Udgivet: (2019-08-01)

Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.
af: Ferner, R, et al.
Udgivet: (2013)

The appropriate use of human albumin in a Brazilian University Hospital: therapeutic indication and dosage regimen
af: Tatiane Sayuri Ishida, et al.
Udgivet: (2019-04-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
af: Cipriani, A, et al.
Udgivet: (2005)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
af: Xiangqing Song, et al.
Udgivet: (2022-06-01)

Monitoring for harms of therapy.
af: Aronson, J
Udgivet: (2006)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
af: A-Xi Shi, et al.
Udgivet: (2023-07-01)

Optimizing vancomycin dosage regimen at the University Medical Center Maribor
af: Maja Cvikl, et al.
Udgivet: (2011-12-01)

DISPOSITION KINETICS AND DOSAGE REGIMEN OF INTRAVENOUSLY INJECTED KANAMYCIN IN BUFFALOES
af: T. Saeed, R. Ahmad, M. Nawaz1 and T. Iqbal
Udgivet: (2000-01-01)

Dosage regimen and toxicity risk assessment of linezolid in sepsis patients
af: Linjie Dou, et al.
Udgivet: (2020-07-01)

Dosage adjustment in renal insufficiency: comparison between databases
af: Isabella Faria MARANHÃO, et al.
Udgivet: (2024-03-01)

Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage
af: M. de Jong, et al.
Udgivet: (2023-12-01)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
af: Myriam Briki, et al.
Udgivet: (2023-04-01)

Adverse drug reactions--no farewell to harms.
af: Aronson, J
Udgivet: (2007)

Scheduled dosage regimen by irreversible electroporation of loaded erythrocytes for cancer treatment
af: Wencheng Peng, et al.
Udgivet: (2023-12-01)

Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen
af: Ji-Hun Jang, et al.
Udgivet: (2023-01-01)

Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019
af: Kiatkriangkrai Koyratkoson, et al.
Udgivet: (2022-07-01)

Market harms and market benefits
af: Wilkinson, H
Udgivet: (2022)

Balance between solitude and socializing: everyday solitude time both benefits and harms well-being
af: Netta Weinstein, et al.
Udgivet: (2023-12-01)

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
af: Natasha Strydom, et al.
Udgivet: (2024-08-01)

Optimising dosage of Lytag used as coarse aggregate in lightweight aggregate concretes
af: S Ahmad, et al.
Udgivet: (2013-04-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
af: Onakpoya, I, et al.
Udgivet: (2018)

Optimisation of BMP-2 dosage for the osseointegration of porous titanium implants in an ovine model
af: EB Hunziker, et al.
Udgivet: (2016-11-01)

Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen
af: A. I. Kochetkov, et al.
Udgivet: (2019-09-01)

Individualization of the Dosage Regimen of Erythropoietin is Crucial in End-stage Renal Disease Patients
af: M. K. Krishnapriya, et al.
Udgivet: (2023-03-01)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
af: Jung JA, et al.
Udgivet: (2015-09-01)

Influence of potential gene polymorphisms on propofol dosage regimen in patients undergoing abdominal hysterectomy
af: Ivanov E, et al.
Udgivet: (2021-03-01)

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
af: Patrícia Soares Silva Montagner, et al.
Udgivet: (2023-08-01)

Critical Overview on the Benefits and Harms of Aspirin
af: Chun Shing Kwok, et al.
Udgivet: (2010-05-01)

Dietary Supplements in Childhood — Harm or Benefit?
af: Anatoly I. Khavkin, et al.
Udgivet: (2025-02-01)